| Product Code: ETC12962849 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Fiji continued to rely on key suppliers such as Australia, New Zealand, India, Bangladesh, and the USA for its naltrexone and buprenorphine imports. Despite a high Herfindahl-Hirschman Index indicating market concentration, the industry saw steady growth with a 6.89% CAGR from 2020 to 2024. However, a notable decline in growth rate of -15.21% from 2023 to 2024 suggests a possible shift in market dynamics. Monitoring these trends will be crucial for stakeholders in the pharmaceutical industry operating in Fiji.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Naltrexone Buprenorphine Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Naltrexone Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Naltrexone Buprenorphine Market - Industry Life Cycle |
3.4 Fiji Naltrexone Buprenorphine Market - Porter's Five Forces |
3.5 Fiji Naltrexone Buprenorphine Market Revenues & Volume Share, By Formulation Type, 2021 & 2031F |
3.6 Fiji Naltrexone Buprenorphine Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 Fiji Naltrexone Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Fiji Naltrexone Buprenorphine Market Revenues & Volume Share, By Administration Method, 2021 & 2031F |
3.9 Fiji Naltrexone Buprenorphine Market Revenues & Volume Share, By Patient Group, 2021 & 2031F |
4 Fiji Naltrexone Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of medication-assisted treatment for opioid addiction |
4.2.2 Growing government initiatives and funding for substance abuse treatment programs |
4.2.3 Rise in opioid addiction cases leading to higher demand for naltrexone and buprenorphine |
4.3 Market Restraints |
4.3.1 Stringent regulations and licensing requirements for prescribing naltrexone and buprenorphine |
4.3.2 Limited accessibility to addiction treatment facilities in remote areas of Fiji |
5 Fiji Naltrexone Buprenorphine Market Trends |
6 Fiji Naltrexone Buprenorphine Market, By Types |
6.1 Fiji Naltrexone Buprenorphine Market, By Formulation Type |
6.1.1 Overview and Analysis |
6.1.2 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Formulation Type, 2021 - 2031F |
6.1.3 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Oral Tablet, 2021 - 2031F |
6.1.4 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Sublingual Film, 2021 - 2031F |
6.1.5 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Injectable Form, 2021 - 2031F |
6.1.6 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Implant, 2021 - 2031F |
6.1.7 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Combination Form, 2021 - 2031F |
6.2 Fiji Naltrexone Buprenorphine Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Opioid Receptor Modulation, 2021 - 2031F |
6.2.3 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Partial Agonist, 2021 - 2031F |
6.2.4 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Long-Acting Effect, 2021 - 2031F |
6.2.5 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Sustained Release, 2021 - 2031F |
6.2.6 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Dual Mechanism, 2021 - 2031F |
6.3 Fiji Naltrexone Buprenorphine Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Opioid Dependence, 2021 - 2031F |
6.3.3 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Withdrawal Management, 2021 - 2031F |
6.3.4 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Relapse Prevention, 2021 - 2031F |
6.3.5 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Maintenance Therapy, 2021 - 2031F |
6.3.6 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Detoxification, 2021 - 2031F |
6.4 Fiji Naltrexone Buprenorphine Market, By Administration Method |
6.4.1 Overview and Analysis |
6.4.2 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.4.3 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Sublingual, 2021 - 2031F |
6.4.4 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Injection, 2021 - 2031F |
6.4.5 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.6 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5 Fiji Naltrexone Buprenorphine Market, By Patient Group |
6.5.1 Overview and Analysis |
6.5.2 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Adults, 2021 - 2031F |
6.5.3 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Teenagers, 2021 - 2031F |
6.5.4 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Elderly, 2021 - 2031F |
6.5.5 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By Critical Patients, 2021 - 2031F |
6.5.6 Fiji Naltrexone Buprenorphine Market Revenues & Volume, By All Ages, 2021 - 2031F |
7 Fiji Naltrexone Buprenorphine Market Import-Export Trade Statistics |
7.1 Fiji Naltrexone Buprenorphine Market Export to Major Countries |
7.2 Fiji Naltrexone Buprenorphine Market Imports from Major Countries |
8 Fiji Naltrexone Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare providers trained in prescribing naltrexone and buprenorphine |
8.2 Rate of successful treatment outcomes with naltrexone and buprenorphine |
8.3 Percentage of opioid addiction cases opting for medication-assisted treatment |
9 Fiji Naltrexone Buprenorphine Market - Opportunity Assessment |
9.1 Fiji Naltrexone Buprenorphine Market Opportunity Assessment, By Formulation Type, 2021 & 2031F |
9.2 Fiji Naltrexone Buprenorphine Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 Fiji Naltrexone Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Fiji Naltrexone Buprenorphine Market Opportunity Assessment, By Administration Method, 2021 & 2031F |
9.5 Fiji Naltrexone Buprenorphine Market Opportunity Assessment, By Patient Group, 2021 & 2031F |
10 Fiji Naltrexone Buprenorphine Market - Competitive Landscape |
10.1 Fiji Naltrexone Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 Fiji Naltrexone Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here